Small artery remodelling in hypertension: Causes, consequences and therapeutic implications

Medical and Biological Engineering and Computing

Volumn 46, Issue 5, 2008, Pages 461-467

  Mulvany, Michael J ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Cardiovascular risk; Essential hypertension; Inward eutrophic remodelling; Outward remodelling; Prognosis; Resistance vasculature; Small artery; Tissue transglutaminase; Vascular tone; Vasodilator therapy

Indexed keywords

BIOMEDICAL ENGINEERING; BLOOD; BLOOD VESSELS; PATHOLOGY; TISSUE;

CARDIOVASCULAR RISK; ESSENTIAL HYPERTENSION; PROGNOSIS; RESISTANCE VASCULATURE; SMALL ARTERY; TISSUE TRANSGLUTAMINASE; VASCULAR TONE; VASODILATOR THERAPY;

CARDIOVASCULAR SYSTEM;

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CELL FUNCTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; ESSENTIAL HYPERTENSION; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROGNOSIS; RESISTANCE BLOOD VESSEL; UNSPECIFIED SIDE EFFECT; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIES; HUMANS; HYPERTENSION; MICROCIRCULATION; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 42549104688     PISSN: 01400118     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11517-008-0305-3     Document Type: Article

References (60)

1. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ (1987) Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 61:181-186
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288(23):2981-2997
3. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA (1999) Structural skin capillary rarefaction in essential hypertension. Hypertension 33(4):998-1001
4. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, VanBavel E (2005) Small artery remodeling depends on tissue-type transglutaminase. Circ Res 96(1):119-126
5. Bakker EN, Buus CL, VanBavel E, Mulvany MJ (2004) Activation of resistance arteries with endothelin-1: From vasoconstriction to functional adaptation and remodeling. J Vasc Res 41(2):174-182
6. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van RN, Candi E, VanBavel E (2006) Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: Possible compensation by macrophage-derived factor XIII. Circ Res 99(1):86-92
7. Bakker EN, van Der Meulen ET, Spaan JA, VanBavel E (2001) Organoid culture of cannulated rat resistance arteries: Effect of serum factors on vasoactivity and remodeling. Am J Physiol 278:H1233-H1240
8. Bakker EN, van Der Meulen ET, van den Berg BM, Everts V, Spaan JA, VanBavel E (2002) Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 39(1):12-20
9. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 39(1):10-15
10. Buus NH, Bottcher M, Jorgensen CG, Christensen KL, Thygesen K, Nielsen TT, Mulvany MJ (2004) Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 44(4):465-470
11. Christensen KL, Mulvany MJ (2001) Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: A literature survey. J Hypertens 19:1001-1006
12. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de FU, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H (2002) Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359(9311):995-1003
13. Deng LY, Li JS, Schiffrin EL (1995) Endothelium-dependent relaxation of small arteries from essential hypertensive patients: Mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci Colch 88:611-622
14. Dustan HP (2000) History of clinical hypertension: From 1827 to 1970. In: Oparil S, Weber MA (eds) Hypertension. Saunders WB, Philadelphia, pp 1-4
15. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C, Buus CL, Mulvany MJ (2007) Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res (in press)
16. Falloon BJ, Heagerty AM (1994) In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 24:16-23
17. Fesus L, Piacentini M (2002). Transglutaminase 2: An enigmatic enzyme with diverse functions. Trends Biochem Sci 27(10):534-539
18. Folkow B (1956) Structural, myogenic, humoral and nervous factors controlling peripheral resistance. In: Harington M (ed) Hypotensive drugs. Pergamon, London, pp 163-174
19. Fridman KU, Wysocki M, Friberg PR, Andersson OK (1999) Candesartan cilexetil in hypertension: Effects of six weeks' treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-aldosterone system. Blood Press 8(4):242-247
20. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: Nature's biological glues. Biochem J 368(Pt 2):377-396
21. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ (1993) Small artery structure in hypertension - dual processes of remodeling and growth. Hypertension 21(4):391-397
22. Heerkens EH, Shaw L, Ryding A, Brooker G, Mullins JJ, Austin C, Ohanian V, Heagerty AM (2006) alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension 47(2):281-287
23. Hollander W, Wilkins RW (2007) Chlorothiazide: A new type of drug for the treatment of arterial hypertension. BMQ 8:69-71
24. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA (2006) Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354(16):1685-1697
25. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ (1993) Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 22:523-526
26. Kuschnir E (1999) Impact of calcium antagonists on the cardiovascular system: Experience with lacidipine. Drugs 57(Suppl 1):11-17
27. Lund-Johansen P (1970) Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide. Acta Med Scand 187(6):509-518
28. Lund-Johansson P (1980) Haemodynamics in essential hypertension. Clin Sci 59:343-354
29. Mancia G, Grassi G, Giannattasio C, Seravalle G (1999) Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34(4 Pt 2):724-728
30. Martinez-Lemus LA, Hill MA, Bolz SS, Pohl U, Meininger GA (2004) Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: Implications for functional remodeling. Faseb J 18(6):708-710
31. Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ, Christensen KL (2007) Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 25(5):1027-1034
32. Mathiassen ON, Buus NH, Olsen HW, Larsen ML, Mulvany MJ, Christensen KL (2006) Forearm plethysmography in the assessment of vascular tone and resistance vasculature design: New methodological insights. Acta Physiol (Oxf) 188(2):91-101
33. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL (2007) Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25(5):1021-1026
34. Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: Principal results. Br Med J 291:97-104
35. Mulvany MJ, Halpern W (1976) Mechanical properties of vascular smooth muscle cells in situ. Nature 269:617-619
36. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD (1996) Vascular remodelling (letter to editor). Hypertension 28:505-506
37. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27(3):193-202
38. Oparil S, Izzo JL Jr (2006) Pulsology rediscovered: Commentary on the conduit artery function evaluation (CAFE) study. Circulation 113(9):1162-1163
39. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL (1998) Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan cilexetil study investigators. Am. J Cardiol 82(8):961-965
40. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E (2003). Prognostic significance of small-artery structure in hypertension. Circulation 108(18):2230-2235
41. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti Rosei E (1996) Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 28:785-790
42. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rosei EA (2001). Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 103(9):1238-1244
43. Rosei EA, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Bettoni G (1995) Media: Lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 13:341-347
44. Schafer S, Kelm M, Mingers S, Strauer BE (2002) Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 20(7):1431-1437
45. Schiffrin EL, Deng LY (1996) Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens 14(10):1247-1255
46. Schiffrin EL, Deng LY, Larochelle P (1994) Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 23:83-91
47. Schiffrin EL, Deng LY, Larochelle P (1992) Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J. Hypertens 10:437-444
48. Schiffrin EL, Park JB, Intengan HD, Touyz RM (2000) Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101:1653-1659
49. Schiffrin EL, Park JB, Pu Q (2002) Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 20(1):71-78
50. Schofield I, Malik R, Izzard A, Austin C, Heagerty A (2002) Vascular structural and functional changes in type 2 diabetes mellitus: Evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 106(24):3037-3043
51. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE (1993). Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 88(3):993-1003
52. Sihm I, Schroeder AP, Aalkjaer C, Mulvany MJ, Thygesen K, Lederballe O (1998) Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: A comparison between calcium channel blocker and thiazide-based regimens. Am J Hypertens 11:263-271
53. Skov K, Eiskjaer H, Hansen HE, Madsen JK, Kvist S, Mulvany MJ (2007) Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker. Hypertension 50(1):39-40
54. Sorop O, Bakker EN, Pistea A, Spaan JA, VanBavel E (2006) Calcium channel blockade prevents pressure-dependent inward remodeling in isolated subendocardial resistance vessels. Am J Physiol Heart Circ Physiol 291(3):H1236-H1245
55. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ (1994) Dose-dependent effects of perindopril on blood pressure and on small artery structure. Hypertension 23:659-666
56. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ (1995) Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 25:474-481
57. Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141(3):334-341
58. Vecchione C, Fratta L, Rizzoni D, Notte A, Poulet R, Porteri E, Frati G, Guelfi D, Trimarco V, Mulvany MJ, Agabiti-Rosei E, Trimarco B, Cotecchia S, Lembo G (2002) Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation 105(14):1700-1707
59. Veterans Administration Cooperative Study (1967) Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. J Am Med Assoc 202:1028-1034
60. Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR, Johnston CI, Mcneil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ, Nelson M, Bruce A, Beckinsale P, Thompson J, McMurchie M, Fraser G, Gleave D, Cope V, DeLooze F, Moore S, Dibben C, Newbury J, Miles H, McDermott B, Willson K, Bear C, West M, Harrap S, Johnston C, Beilin L, Ryan P, Wing L, Reid C, Beilin L, Brown M, Ryan P, Wing L, Reid C, Jennings G, Fletcher P, Feneley M, Dewar E, Wing L, Reid C, McNeil J, Wing L, Marley J, Reid C, Johnston C, Jennings G, Wing L, Reid C, Marley J, Moss J, Webb P, Glasziou P, Boyle F, Primrose J, Wing L, Reid C, Steven I, Piterman L, De Looze F, Dickinson J, Gambrill J, Joseph P, Reid C, Hunt D, Donnan G, Wing L, Morgan T, Chalmers J, Whitworth J, MacMahon S, Silagy C (2003) A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348(7):583-592